跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
AYVAKYT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
AYVAKYT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Blueprint Medicines (Netherlands) B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 26, 2022
Approval ID
cd1a591da150e281
Company
Blueprint Medicines (Netherlands) B.V.
Type
Standard
Approval Details
Approval Id
cd1a591da150e281
Drug Cima Aemps Name
AYVAKYT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1201473002
Holder Company Name
Blueprint Medicines (Netherlands) B.V.
Marketing Company Name
Blueprint Medicines (Netherlands) B.V.
Holder Company Detail Path
/organization/blueprint-medicines-netherlands-bv
Marketing Company Detail Path
/organization/blueprint-medicines-netherlands-bv
Authorization Date
2022-05-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
200 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Blueprint Medicines (Netherlands) B.V.
Company Detail Path
/organization/blueprint-medicines-netherlands-bv
Company Information
Pharmaceutical Company Name
Blueprint Medicines (Netherlands) BV
Country Name
Netherlands
Active Ingredients
AVAPRITINIB
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 26, 2022
Approval ID
cd1a591da150e281
Type
Standard
Back to CIMA-AEMPS Approvals
AYVAKYT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details